Evaluation of the potential utility of flat panel CT for quantifying relative contrast enhancement

Por Jones, A. Kyle, Mahvash, Armeen
Publicado em 2012

Blood flow diversion using the microvascular plug to avoid non target delivery of radioactive microspheres

Por Abdelsalam, Mohamed E., Kappadath, S. Cheenu, Mahvash, Armeen
Publicado no Radiol Case Rep (2020)

Can imaging patterns of neuroendocrine hepatic metastases predict response yttruim-90 radioembolotherapy?

Por Neperud, Julia, Mahvash, Armeen, Garg, Naveen, Murthy, Ravi, Szklaruk, Janio
Publicado em 2013

Comparing voxel-based absorbed dosimetry methods in tumors, liver, lung, and at the liver-lung interface for (90)Y microsphere selective internal radiation therapy

Por Mikell, Justin K, Mahvash, Armeen, Siman, Wendy, Mourtada, Firas, Kappadath, S Cheenu
Publicado no EJNMMI Phys (2015)

Selective internal radiation therapy with 90Y glass microspheres: biases and uncertainties in absorbed dose calculations between clinical dosimetry models

Por Mikell, Justin K., Mahvash, Armeen, Siman, Wendy, Baladandayuthapani, Veera, Mourtada, Firas, Kappadath, S. Cheenu
Publicado no Int J Radiat Oncol Biol Phys (2016)

Temporary Balloon Occlusion of the Common Hepatic Artery for Yttrium-90 Glass Microspheres Administration in a Patient with Hepatocellular Cancer and Renal Insufficiency

Por Smith, Justin, Murthy, Ravi, Lahoti, Amit, Odisio, Bruno, Avritscher, Rony, Chasen, Beth, Mahvash, Armeen
Publicado em 2013

Minimally invasive image-guided therapies for hepatocellular carcinoma

Por Abdelsalam, Mohamed E, Murthy, Ravi, Avritscher, Rony, Mahvash, Armeen, Wallace, Michael J, Kaseb, Ahmed O, Odisio, Bruno C
Publicado no J Hepatocell Carcinoma (2016)

Baseline Apparent Diffusion Coefficient as a Predictor of Response to Liver-Directed Therapies in Hepatocellular Carcinoma

Por Niekamp, Andrew, Abdel-Wahab, Reham, Kuban, Joshua, Odisio, Bruno C., Mahvash, Armeen, Hassan, Manal M., Qayyum, Aliya, Kaseb, Ahmed, Sheth, Rahul A.
Publicado no J Clin Med (2018)

Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume including a comparison to the ALPPS appro...

Por Shindoh, Junichi, Vauthey, Jean-Nicolas, Zimmitti, Giuzeppe, Curley, Steven A., Huang, Steven Y, Mahvash, Armeen, Gupta, Sanjay, Wallace, Michael J, Aloia, Thomas A
Publicado em 2013

Reversible Ureteral Obstruction due to Polyomavirus Infection after Precutaneous Nephrostomy Catheter Placement

Por Khan, Hassan, Oberoi, Shilpa, Mahvash, Armeen, Sharma, Manish, Rondon, Gabriela, Alousi, Amin, Shpall, Elizabeth J., Kontoyiannis, Dimitrios P., Champlin, Richard E., Ciurea, Stefan O.
Publicado no Biol Blood Marrow Transplant (2011)

Portomesenteric Venous Stenting for Palliation of Ascites and Variceal Bleeding Caused by Prehepatic Portal Hypertension

Por Sheth, Rahul A., Sabir, Sharjeel H., Parmet, Philip, Amin, Roshon, Kuban, Joshua D., Huang, Steven Y., Mahvash, Armeen, Fogelman, David, Javle, Milind, Wallace, Michael J.
Publicado no Oncologist (2017)

Kinetic Growth Rate after Portal Vein Embolization Predicts Posthepatectomy Outcomes: Toward Zero Liver-Related Mortality in Patients with Colorectal Liver Metastases and Small Fut...

Por Shindoh, Junichi, Truty, Mark J, Aloia, Thomas A, Curley, Steven A, Zimmitti, Giuseppe, Huang, Steven Y, Mahvash, Armeen, Gupta, Sanjay, Wallace, Michael J, Vauthey, Jean-Nicolas
Publicado em 2012

A Machine Learning Model to Predict Hepatocellular Carcinoma Response to Transcatheter Arterial Chemoembolization

Por Morshid, Ali, Elsayes, Khaled M., Khalaf, Ahmed M., Elmohr, Mohab M., Yu, Justin, Kaseb, Ahmed O., Hassan, Manal, Mahvash, Armeen, Wang, Zhihui, Hazle, John D., Fuentes, David
Publicado no Radiol Artif Intell (2019)

Optimal Future Liver Remnant in Patients Treated with Extensive Preoperative Chemotherapy for Colorectal Liver Metastases

Por Shindoh, Junichi, Tzeng, Ching-Wei D., Aloia, Thomas A., Curley, Steven A., Zimmitti, Giuseppe, Wei, Steven H., Huang, Steven Y., Mahvash, Armeen, Gupta, Sanjay, Wallace, Michael J., Vauthey, Jean-Nicolas
Publicado em 2013

Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients

Por Teyateeti, Ajalaya, Mahvash, Armeen, Long, James P, Abdelsalam, Mohamed E, Avritscher, Rony, Chasen, Beth, Kaseb, Ahmed O, Kuban, Joshua D, Murthy, Ravi, Odisio, Bruno C, Teyateeti, Achiraya, Macapinlac, Homer A, Kappadath, S Cheenu
Publicado no J Hepatocell Carcinoma (2020)

Efficacy of a Self-Expanding Tract Sealant Device in the Reduction of Pneumothorax and Chest Tube Placement Rates after Percutaneous Lung Biopsy: A Matched Controlled Study Using P...

Por Ahrar, Judy U., Gupta, Sanjay, Ensor, Joe E., Mahvash, Armeen, Sabir, Sharjeel H., Steele, Joseph R., McRae, Stephen E., Avritscher, Rony, Huang, Steven Y., Odisio, Bruno C., Murthy, Ravi, Ahrar, Kamran, Wallace, Michael J., Tam, Alda L.
Publicado no Cardiovasc Intervent Radiol (2016)

Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma

Por Mahvash, Armeen, Murthy, Ravi, Odisio, Bruno C, Raghav, Kanwal Pratap, Girard, Lauren, Cheung, Sheree, Nguyen, Van, Ensor, Joe, Gadani, Sameer, Elsayes, Khaled M, Abdel-Wahab, Reham, Hassan, Manal, Shalaby, Ahmed S, Yao, James C, Wallace, Michael J, Kaseb, Ahmed O
Publicado no J Hepatocell Carcinoma (2016)

NATURAL HISTORY OF T1N0M0 HEPATOCELLULAR CARCINOMA: LARGE SCALE STUDY IN THE UNITED STATES

Por Alshamsi, Humaid O., Abdel-Wahab, Reham, Hassan, Manal M., Shalaby, Ahmed S., Dahbour, Ibrahim, Lacin, Sahin, Mahvash, Armeen, Odisio, Bruno C., Murthy, Ravi, Avritscher, Rony, Abdelsalam, Mohamed E., Rashid, Asif, Vauthey, Jean-Nicolas, Aloia, Thomas A., Conrad, Claudius, Chun, Yun Shin, Krishnan, Sunil, Das, Prajnan, Koay, Eugene J., Yao, James, Kaseb, Ahmed O.
Publicado no Oncology (2017)

Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study

Por Morris, Van K, Salem, Mohamed E, Nimeiri, Halla, Iqbal, Syma, Singh, Preet, Ciombor, Kristen, Polite, Blase, Deming, Dustin, Chan, Emily, Wade, James L, Xiao, Lianchun, Bekaii-Saab, Prof Tanios, Vence, Luis, Blando, Jorge, Mahvash, Armeen, Foo, Wai Chin, Ohaji, Chimela, Pasia, Manolo, Bland, Gail, Ohinata, Aki, Rogers, Jane, Mehdizadeh, Amir, Banks, Kimberly, Lanman, Richard, Wolff, Robert A, Streicher, Howard, Allison, Prof James, Sharma, Prof Padmanee, Eng, Prof Cathy
Publicado no Lancet Oncol (2017)

Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation

Por Xing, Yan, Lin, Nancy U., Maurer, Matthew A., Chen, Huiqin, Mahvash, Armeen, Sahin, Aysegul, Akcakanat, Argun, Li, Yisheng, Abramson, Vandana, Litton, Jennifer, Chavez-MacGregor, Mariana, Valero, Vicente, Piha-Paul, Sarina A., Hong, David, Do, Kim-Anh, Tarco, Emily, Riall, Dianna, Eterovic, Agda Karina, Wulf, Gerburg M., Cantley, Lewis C., Mills, Gordon B., Doyle, L. Austin, Winer, Eric, Hortobagyi, Gabriel N., Gonzalez-Angulo, Ana Maria, Meric-Bernstam, Funda
Publicado no Breast Cancer Res (2019)